BTEC vs. XBI
Compare and contrast key facts about Principal Healthcare Innovators Index ETF (BTEC) and SPDR S&P Biotech ETF (XBI).
BTEC and XBI are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BTEC is a passively managed fund by Principal that tracks the performance of the NASDAQ U.S. Health Care Innovators Index. It was launched on Aug 19, 2016. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006. Both BTEC and XBI are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BTEC or XBI.
Key characteristics
| BTEC | XBI | |
|---|---|---|
| YTD Return | -1.19% | -2.20% |
| 1Y Return | 3.96% | 9.55% |
| 3Y Return (Ann) | -15.50% | -13.87% |
| 5Y Return (Ann) | 1.85% | 0.31% |
| Sharpe Ratio | 0.06 | 0.23 |
| Daily Std Dev | 26.76% | 28.31% |
| Max Drawdown | -62.91% | -63.89% |
| Current Drawdown | -48.80% | -49.78% |
Correlation
The correlation between BTEC and XBI is 0.81, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
BTEC vs. XBI - Performance Comparison
In the year-to-date period, BTEC achieves a -1.19% return, which is significantly higher than XBI's -2.20% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BTEC vs. XBI - Expense Ratio Comparison
BTEC has a 0.42% expense ratio, which is higher than XBI's 0.35% expense ratio.
Risk-Adjusted Performance
BTEC vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Principal Healthcare Innovators Index ETF (BTEC) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BTEC vs. XBI - Dividend Comparison
BTEC has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BTEC Principal Healthcare Innovators Index ETF | 0.00% | 0.00% | 0.00% | 0.96% | 0.37% | 0.00% | 0.00% | 0.13% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.02% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
Drawdowns
BTEC vs. XBI - Drawdown Comparison
The maximum BTEC drawdown since its inception was -62.91%, roughly equal to the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for BTEC and XBI. For additional features, visit the drawdowns tool.
Volatility
BTEC vs. XBI - Volatility Comparison
Principal Healthcare Innovators Index ETF (BTEC) has a higher volatility of 8.29% compared to SPDR S&P Biotech ETF (XBI) at 7.82%. This indicates that BTEC's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.